BioWorld Data: Metrics and Analysis for Biopharma Decision Makers - Plus Biosimilars Whitepaper

This is a paid advertisement for SmartBrief readers.

The content does not necessarily reflect the view of SmartBrief or its Association partners.

If you are having trouble viewing this message in your e-mail client, please see the web version here

Save 20% on your order when you purchase both data reports Use coupon code Data20SB at checkout to receive your immediate discount Click Here for your complimentary biosimilars whitepaper: An Outlook on US Biosimilar Competition Biopharmaceutical Royalty Rates Analysis: Essential Benchmarks for Dealmaking   Analysis and background information on 320 biopharmaceutical licensing      deals   Real-world data specifics on deal terms such as royalty rates, milestones      and up-fronts   Hot disease topics including Alzheimer's, cancer, cardiovascular, diabetes,      hepatitis, pain management and more! The Biosimilars Game: A Scorecard for Opportunities, Threats and Critical Strategies      In-depth, current review of the biosimilars market in 31 countries      Profiles of 139 key biosimilar developers of 276 biosimilars      Data to spot the Big Hitters, including likely targets identified by the FDA      Biosimilar R & D cost comparisons, deal terms, strategic alliance      and more! Multi-User Licenses Available! Email customerservice@bioworld.com For More Information

About this email: BIO SmartBrief will occasionally send emails from our advertising partners promoting products and services determined to be of interest and relevance to our readers. Each email is carefully considered on a case-by-case basis. If you do not want to receive these emails, you can unsubscribe from them by clicking here. SmartBrief, Inc.® 555 11th ST NW, Suite 600, Washington, DC 20004